<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01402739</url>
  </required_header>
  <id_info>
    <org_study_id>HEART-PoC</org_study_id>
    <nct_id>NCT01402739</nct_id>
  </id_info>
  <brief_title>Algorithm-Guided Transfusions in Cardiac Surgery Patients for Reduction of Drainage Blood Losses</brief_title>
  <acronym>HEART-PoC</acronym>
  <official_title>Monocentric Pilot Study of Algorithm-Guided Transfusions in Cardiac Surgery Patients for Reduction of Drainage Blood Losses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Michael Sander</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac surgery patients have a risk to need allogeneic blood transfusions that depends on
      several risk factors, e.g. the type of surgery, concomitant medication with anticoagulants,
      and postoperative chest tube output. Allogeneic blood transfusion is associated with
      transfusion reactions, infection transmission, and postoperative morbidity and mortality. The
      aim of this study is to investigate, whether cardiac surgery patients have a reduced
      postoperative chest tube output and transfusion need when using a point-of-care guided
      transfusion algorithm compared to standard of care transfusion protocols.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiac surgery patients have a risk to need allogeneic blood transfusions that depends on
      several risk factors, e.g. the type of surgery, concomitant medication with anticoagulants,
      and postoperative chest tube output. Allogeneic blood transfusion is associated with
      transfusion reactions, infection transmission, and postoperative morbidity and mortality. The
      aim of this study is to investigate, whether cardiac surgery patients have a reduced
      postoperative chest tube output and transfusion need when using a point-of-care guided
      transfusion algorithm compared to standard of care transfusion protocols .
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study terminated prematurely due to futility
  </why_stopped>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>chest tube output</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>need of allogeneic blood transfusions</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>course of conventional coagulation parameters (aPTT, TPZ, fibrinogen, FXIII, ACT)</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of mechanical ventilation</measure>
    <time_frame>hours (average)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of RRT</measure>
    <time_frame>during 30 days</time_frame>
    <description>or until hospital discharge, whatever is earlier</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Chest Tube Output</condition>
  <condition>Allogeneic Blood Transfusions</condition>
  <arm_group>
    <arm_group_label>PoC algorithm guided transfusions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>experimental arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard of care transfusions</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>control arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Point of Care Coagulation Monitoring Guided Transfusion Algorithm</intervention_name>
    <description>(thromboelastometry, aggregometry, blood gas analysis)</description>
    <arm_group_label>PoC algorithm guided transfusions</arm_group_label>
    <other_name>ROTEM delta, Multiplate, ABL 725</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard coagulation monitoring guided transfusion algorithm</intervention_name>
    <description>aPTT, ACT, platelet count, hemoglobin, fibrinogen</description>
    <arm_group_label>standard of care transfusions</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective cardiac surgery patient requiring cardiopulmonary bypass

          -  moderate or high transfusion risk

          -  signed informed consent

        Exclusion Criteria:

          -  age &lt;18 or &gt;80 years

          -  known hemophilia

          -  known thrombophilia

          -  known thrombocytopathy

          -  hereditary or acquired coagulation disorder

          -  active endocarditis

          -  ejection fraction &lt;30%

          -  BSA &lt; 1.8 sqm

          -  planned aortic arch surgery

          -  preoperative thrombocytopenia &lt;150/nl

          -  underlying hemostaseological disease

          -  preoperative anemia

          -  liver cirrhosis Child B or higher

          -  preoperative creatinine &gt; 2mg/dl

          -  terminal renal insufficiency requiring dialysis

          -  vitamin k antagonists during 5 days prior to surgery

          -  pregnant or breast-feeding women

          -  known allergy against allogeneic blood products or coagulation factors

          -  refusal of blood transfusions

          -  any concomitant investigational agent or participation in another trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Sander, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Anesthesiology CCM/CVK Charité Universitätsmedizin Berlin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claudia D Spies, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Dept. of Anesthesiology CCM/CVK Charité Universitätsmedizin Berlin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology CCM/CVK Charité Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2011</study_first_submitted>
  <study_first_submitted_qc>July 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2011</study_first_posted>
  <last_update_submitted>June 12, 2015</last_update_submitted>
  <last_update_submitted_qc>June 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Michael Sander</investigator_full_name>
    <investigator_title>Univ.-Prof. M. Sander</investigator_title>
  </responsible_party>
  <keyword>PoC</keyword>
  <keyword>ROTEM</keyword>
  <keyword>Multiplate</keyword>
  <keyword>transfusion</keyword>
  <keyword>cardiac surgery</keyword>
  <keyword>drainage blood loss</keyword>
  <keyword>chest tube output</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

